Loading resource…

American College of Clinical Pharmacology
Valproic acid (VPA) is highly protein-bound, affecting its free fraction and clearance in patients with low albumin levels. This retrospective cohort study involved adult patients with seizures or epilepsy, comparing adjusted and total VPA levels to assess their correlation with safety and effectiveness outcomes. The study highlights the limited data available on VPA use in hypoalbuminemic patients and aims to provide insights into its clinical implications.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

ADVERSE EVENTS ASSOCIATED WITH FLUMAZENIL TREATMENT FOR THE MANAGEMENT OF SUSPECTED BENZODIAZEPINE INTOXICATION – A SYSTEMATIC REVIEW WITH META-ANALYSES OF RANDOMISED TRIALS
Same clinical topic · Clinical Pharmacology

SPECIAL POPULATION CONSIDERATIONS AND REGULATORY AFFAIRS FOR CLINICAL RESEARCH
Same clinical topic · Clinical Pharmacology

Traumatic Brain Injury
Same resource type · Neurology

ADA Consensus Report: MASLD in People With Diabetes
Same resource type · Endocrinology

Hospital Care for Children Guidelines
Same resource type · Pediatrics

Management of Obesity
Same resource type

CURRENT Diagnosis & Treatment Pediatrics 27th Edition 2025
Same resource type · General Medicine

Classification of the Epilepsies
Same resource type · Neurology

5-Minute Clinical Consult 31E 2023
Same resource type · General Medicine